Perioperative medicine & outcomes

Venous Thromboembolism in Total Hip and Total Knee Arthroplasty

JAMA Netw OpenPublished Retrospective cohort study

Main finding · VTEResult — go to the resultOdds ratio 1.14 95% CI 0.82–1.59

Authors' conclusion

In this cohort study of patients who underwent total hip or total knee arthroplasty, underlying patient risk factors, but not choice of aspirin or DOAC, were associated with postsurgical VTE. Postoperative bleeding rates were lower in patients prescribed aspirin.

Study context

Population
US patients with hip or knee arthroplasty, continuous insurance enrollment 3 months before and after surgery, receiving a single postsurgical pharmacological thromboprophylaxis agent, no preoperative anticoagulation
Participants
29,264 patients · 7,844 matched direct oral anticoagulant (DOAC)-aspirin pairs
Exposure
DOAC vs aspirin thromboprophylaxis after total hip or knee arthroplasty
  • DOACn = 7,844
  • Aspirinn = 7,844reference
Outcome
Cumulative incidence of postdischarge VTE
Follow-up
30 days
Methodological detailsclaims database, propensity-matched analysis
  • Claims database
  • Propensity-matched analysis

Main finding

VTE

Odds ratio

1.14

95% CI 0.82–1.59

DOAC vs Aspirin
OR 1.14 (95% CI 0.82–1.59)

As reported in the abstract

Cumulative incidence of venous thromboembolism (VTE), whole cohort
1.19% (95% CI, 1.06%-1.32%)

Observational data: associations, not effects.

Further findings

Risk factors for VTE (multivariate analysis)

Prior VTE history, OR
5.94 (95% CI, 4.29-8.24)
Hereditary hypercoagulable state, OR
2.64 (95% CI, 1.32-5.28)
Knee arthroplasty, OR
1.65 (95% CI, 1.29-2.10)
Male sex, OR
1.34 (95% CI, 1.08-1.67)

Safety

OutcomeOR (95% CI)
Postoperative bleeding · 30 daysMore frequent with DOACs · propensity-matched cohort1.36 (1.13–1.62)
Postoperative bleeding — Cumulative incidence of bleeding, whole cohort
3.43% (95% CI, 3.22%-3.64%)

Original publication

Venous Thromboembolism in Total Hip and Total Knee Arthroplasty. JAMA Netw Open. Published 1 December 2023. doi:10.1001/jamanetworkopen.2023.45883

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.